Both modalities lead to a variable response in other exerkines including clusterin, lactate, hepatocyte growth factor and interleukin-6.<h4>Conclusion</h4>In COPD, short-duration SupraHIIT is more feasible and enables markedly higher external exercise intensities than MICT. This evidence concerns the gene HGF and chronic obstructive pulmonary disease.